Publications by authors named "Kathleen Colson"

Claim this Profile
A
A Focus on Special Populations in Relapsed Multiple Myeloma.
Mary Steinbach, Kathleen Colson, Beth Faiman

J Adv Pract Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab: Nursing Considerations for Use in the Treatment of Multiple Myeloma.
Jenai Wilmoth, Kathleen Colson, Franck Dubin, Christine Kellam

Clin J Oncol Nurs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma.
Jacob P Laubach, Sascha A Tuchman, Jacalyn M Rosenblatt, Constantine S Mitsiades, Kathleen Colson

Blood Cancer J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib.
Paul G Richardson, Arnon Nagler, Dina Ben-Yehuda, Ashraf Badros, Parameswaran N Hari, Kathleen Colson

EJHaem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma.
Beth Faiman, Deborah Doss, Kathleen Colson, Patricia Mangan, Tracy King

Clin J Oncol Nurs· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma.
Kimberly Noonan, Kathleen Colson

Semin Oncol Nurs· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-related symptom management in patients with multiple myeloma: a review.
Kathleen Colson

Support Care Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.
Paul G Richardson, Wanling Xie, Sundar Jagannath, Andrzej Jakubowiak, Sagar Lonial, Kathleen Colson

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.
Paul G Richardson, Jacob P Laubach, Robert L Schlossman, Irene M Ghobrial, Katherine C Redman, Kathleen Colson

Eur J Haematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial.
Paul G Richardson, Jeff Wolf, Andrzej Jakubowiak, Jeff Zonder, Sagar Lonial, Kathleen Colson

J Clin Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
Teresa S Miceli, Kathleen Colson, Beth M Faiman, Kena Miller, Joseph D Tariman

Clin J Oncol Nurs· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring treatment for multiple myeloma patients with relapsed and refractory disease.
Paul G Richardson, Jacob Laubach, Constantine Mitsiades, Robert L Schlossman, Deborah Doss, Kathleen Colson

Oncology (Williston Park)· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding role of bortezomib in multiple myeloma: nursing implications.
Kathleen Colson, Deborah S Doss, Regina Swift, Joseph Tariman

Cancer Nurs· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.
Page Bertolotti, Elizabeth Bilotti, Kathleen Colson, Kathleen Curran, Deborah Doss

Clin J Oncol Nurs· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelosuppression associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
Teresa Miceli, Kathleen Colson, Maria Gavino, Kathy Lilleby,

Clin J Oncol Nurs· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma.
Paul Richardson, Constantine Mitsiades, Kathleen Colson, Eileen Reilly, Laura McBride

Leuk Lymphoma· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the efficacy and safety of bortezomib in relapsed multiple myeloma.
Paul Richardson, Sundar Jagannath, Kathleen Colson

Clin Adv Hematol Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing care and managing side effects in patients receiving bortezomib.
Kathleen Colson

Clin Adv Hematol Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications.
Kathleen Colson, Deborah S Doss, Regina Swift, Joseph Tariman, Teri E Thomas

Clin J Oncol Nurs· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis